Susanne L. Flanders

Partner
Flanders Susanne
Susanne Flanders is a patent litigator whose practice focuses on biotechnology, chemicals, pharmaceuticals, and medical devices. She has extensive experience litigating Hatch-Waxman cases in district courts across the country.  She also has experience with contested proceedings before the Patent Trial and Appeal Board.   Susanne’s work has involved technologies such as treatments for kidney disease, Alzheimer’s disease, psoriasis, and various types of cancer, including colorectal cancer, pancreatic neuroendocrine tumors, breast cancer, and renal cell carcinoma. Before joining Venable, Susanne spent her entire career at the IP boutique firm Fitzpatrick, Cella, Harper & Scinto.

Experience

Representative Matters

  • Represented Novartis against Breckenridge Pharmaceutical, Inc., West-Ward Pharmaceuticals and Par Pharmaceutical on patents related to Zortress® (everolimus), a drug used to treat kidney and liver transplant patients. (D. Del., Fed. Cir., PTAB-IPR)
  • Represented Novartis against West-Ward Pharmaceuticals on patents related to Afinitor® (everolimus), a drug used for the treatment of renal cell carcinoma and pancreatic neuroendocrine tumors. (D. Del., Fed. Cir., PTAB-IPR)
  • Represented Novartis against Par Pharmaceutical on patents related to Afinitor® (everolimus), a drug used for the treatment of breast cancer. (D. Del.)
  • Represented Novartis against Breckenridge Pharmaceutical, Inc.on patents related to Afinitor® (everolimus), a drug used for the treatment of renal cell carcinoma, renal angiomyolipoma, and tuberous sclerosis complex with subependymal giant cell astrocytoma. (D. Del., PTAB-IPR)
  • Represented Novartis against Mylan Pharmaceuticals  on patents related to Afinitor® Disperz (everolimus), a drug used for the treatment of tuberous sclerosis complex with subependymal giant cell astrocytoma. (D. Del.)
  • Represented Genzyme against Eagle Pharmaceuticals, Ltd. et al. on patents related to Hectorol®, a vitamin D analog used in the treatment of dialysis patients. (D. Del.) 
  • Represented Genzyme against Pentech Pharmaceuticals, Inc. on patents related to Hectorol®, a vitamin D analog used in the treatment of dialysis patients. (N.D. Ill.)
  • Represented LEO Pharma against Tolmar Inc. and Perrigo Inc. on patents related to Taclonex®, a topical anti-psoriatic medication. (D. Del.)

Representative Clients

  • Genzyme
  • LEO Pharma
  • Novartis
  • Sunovion Pharmaceuticals

Insights

Credentials
+

Education

  • J.D. magna cum laude Brooklyn Law School 2008
    • Executive notes and comments editor, Journal of Law and Policy
    • Member, New York Regional First Place Team at the American Association of Justice National Moot Court Competition
  • B.S. Villanova University 2002

Bar Admissions

  • New York 2010
  • New Jersey 2008

Recognition
+

  • Included in Legal 500 for Patent Litigation – Full Coverage, 2018
  • Included in Super Lawyers: New York Metro Edition as a Rising Star in Intellectual Property Litigation, 2015 - 2018
  • Recipient, Judge Edward Thompson Award for Excellence in Trial Advocacy during law school 
 

Community
+

Pro Bono

  • Represented clients in a variety of matters, including claims pertaining to unlawful discriminatory practices and unlawful retaliation under New York City and New York State human rights and corrections laws